Interferon-beta exposure during first trimester is safe in women with multiple sclerosis--A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry

Conclusions: Interferon-beta exposure during early pregnancy does not influence the mean birth weight, risk of preterm birth, or other adverse pregnancy outcomes. Our study provides further reassurance that interferon-beta treatment can be safely continued up until women become pregnant.

http://msj.sagepub.com/cgi/content/abstract/22/6/801?rss=1

Source: Multiple Sclerosis - April 17, 2016 Category: Neurology Authors: Thiel, S., Langer-Gould, A., Rockhoff, M., Haghikia, A., Queisser-Wahrendorf, A., Gold, R., Hellwig, K. Tags: Original Research Papers Source Type: research